Webinar: The Outlook for Cancer Gene Therapies
Date: Monday, June 1, 2020
Time: 2:00 – 2:50 pm ET
What hurdles need to be overcome before gene therapy is a major new modality in the cancer therapy arsenal? Tom VanCott, Chief Technology & Strategy Officer at Catalent Gene Therapy, and other industry experts will discuss manufacturing, viral vectors, and consider the most promising approaches coming to the clinic in this Endpoints webinar.
Tom VanCott, PhD
Chief Technology & Strategy Officer, Catalent Gene Therapy